Lumida
/HUM
⌘K
Humana Inc

Humana Inc

HUM
$409.80USD+2.26%+9.07 today

MARKET CAP

49.2B

P/E (TTM)

23.3x

FWD P/E

31.3x

DAY RANGE

$401 – $411

52W RANGE

$163
$429

AI Summary

Stalk
StalkMedium

HUM is in a Stage 2 advancing phase with bullish medium- and long-term biases underpinned by rising EMAs and a consistent higher-high/lower-low structure. An active Bullish Exhaustion pattern at new highs, along with extreme overbought conditions, signals waning upside momentum and unfavorable short-term timing. Price is extended above the 9/20/50 EMA cluster, so deferred entry on a pullback into that support zone offers a higher-probability engagement point.

  • Q4 2025 revenue $26.8B (+10% YoY) and adjusted EPS $17.14 beat guidance
  • AEP added ~1M members (+20% YoY), with 75% from high-lifetime-value channels
  • Negative earnings yield and weak profitability hinder return generation
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$82.9B$92.5B$105.3B$116.5B$128.6B
YoY %+9.0%+11.6%+13.9%+10.7%+10.3%
P / Sales0.7x0.7x0.6x0.3x0.2x
EV / Sales1.0x0.9x0.8x0.5x0.5x
Gross Profit, Adj.$13.7B$16.8B$16.9B$15.9B$17.8B
YoY %-4.8%+22.8%+0.7%-6.1%+12.0%
Margin %16.5%18.2%16.1%13.6%13.8%
EV / Gross Profit6.2x5.1x5.0x3.7x3.3x
EBITDA, Adj.$3.7B$4.3B$3.9B$2.3B$2.5B
YoY %-17.4%+16.0%-9.4%-40.3%+6.6%
Margin %4.4%4.6%3.7%2.0%1.9%
EV / EBITDA23.1x20.2x21.9x25.4x23.6x
EBIT$3.0B$3.4B$2.9B$1.3B$1.6B
YoY %-22.7%+15.4%-13.9%-54.6%+22.1%
Margin %3.6%3.7%2.8%1.1%1.3%
EV / EBIT28.7x25.2x28.7x43.8x35.5x
Net Income$2.9B$2.8B$2.5B$1.2B$1.2B
YoY %-12.9%-4.3%-11.3%-51.5%-1.6%
Net Margin3.5%3.0%2.4%1.0%0.9%
EPS (GAAP)$22.67$22.08$20.00$9.98$9.84
YoY %-10.4%-2.6%-9.4%-50.1%-1.4%